Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: A single-center experience

Annals of Hematology

Volumn 90, Issue 5, 2011, Pages 529-537

  Li, Yingmei ^a   Li, Xingxin ^a   Ge, Meili ^a   Shi, Jun ^a   Qian, Linsheng ^a   Zheng, Yizhou ^a   Wang, Jianxiang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Acute myeloid leukemia; Aplastic anemia; Clonal evolution; Myelodysplastic syndrome; Paroxysmal nocturnal hemoglobinuria

Indexed keywords

ANDROGEN; CYCLOSPORIN A; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; APLASTIC ANEMIA; ARTICLE; CHILD; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79956085129     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-010-1140-9     Document Type: Article

References (42)

1. Young N, Griffith P, Brittain E, Elfenbein G, Gardner F, Huang A, Harmon D, Hewlett J, Fay J, Mangan K (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 72:1861-1869 (Pubitemid 19030870)
2. Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 95:1931-1934
3. Locasciulli A, Oneto R, Bacigalupo A, Socié G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Führer M (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 92:11-18. doi:10.3324/haematol.10075 (Pubitemid 46232653)
4. Passweg JR, Tichelli A (2009) Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Haematologica 94:310-312. doi:10.3324/haematol.2008.002329
5. Tichelli A, Gratwohl A, Würsch A, Nissen C, Speck B (1988) Late haematological complications in severe aplastic anaemia. Br J Haematol 69:413-418. doi:10.1111/j.1365-2141.1988.tb02382.x
6. de Planque MM, Bacigalupo A, Würsch A, Hows JM, Devergie A, Frickhofen N, Brand A, Nissen C (1989) Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br J Haematol 73:121-126. doi:10.1111/j.1365-2141.1988.tb02382.x
7. Tichelli A, Gratwohl A, Nissen C, Signer E, Stebler Gysi C, Speck B (1992) Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin. Blood 80:337-345
8. Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E (1993) Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation - Severe Aplastic Anaemia Working Party. N Engl J Med 329:1152-1157
9. Kojima S, Ohara A, Tsuchida M, Kudoh T, Hanada R, Okimoto Y, Kaneko T, Takano T, Ikuta K, Tsukimoto I (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 100:786-790 (Pubitemid 34832602)
10. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS (2002) Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 99:3129-3135 (Pubitemid 34525289)
11. Bagby GC, Meyers G (2007) Bone marrow failure as a risk factor for clonal evolution: prospects for leukemia prevention. Hematology Am Soc Hematol Educ Program 2007:40-46
12. Kaito K, Kobayashi M, Katayama T, Masuoka H, Shimada T, Nishiwaki K, Sekita T, Otsubo H, Ogasawara Y, Hosoya T (1998) Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol 103:297-303. doi:10.1046/j.1365-2141.1998.01014. x (Pubitemid 28522429)
13. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, Sasaki H, Okamura J, Sugita K, Kigasawa H, Kiriyama Y, Akatsuka J, Tsukimoto I (1997) Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 90:1009-1013 (Pubitemid 27314134)
14. Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, Sugita K, Yabe H, Ohara A, Tsukimoto I (2000) Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96:2049-2054
15. Imashuku S, Hibi S, Bessho F, Tsuchida M, Nakahata T, Miyazaki S, Tsukimoto I, Hamajima N (2003) Detection of myelodysplastic syndrome/acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF. Haematologica 88:ECR31
16. Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A, Omine M, Mizoguchi H (2007) Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood 110:1756-1761. doi:10.1182/blood-2006-11-050526 (Pubitemid 47443885)
17. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48:63-70
18. Zheng Y, Liu Y, Chu Y (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Exp Hematol 34:826-831. doi:10.1016/j.exphem.2006.03.017 (Pubitemid 43949184)
19. Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937-951. doi:10.1182/blood-2009-03-209262
20. Socie G, Mary JY, Schrezenmeier H, Marsh J, Bacigalupo A, Locasciulli A, Fuehrer M, Bekassy A, Tichelli A, Passweg J (2007) Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood 109:2794-2796. doi:10.1182/blood-2006-07- 034272 (Pubitemid 46482073)
21. Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289:1130-1135 (Pubitemid 37430327)
22. Gurion R, Gafter-Gvili A, Paul M, Vidal L, Ben-Bassat I, Yeshurun M, Shpilberg O, Raanani P (2009) Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy - systematic review and meta-analysis. Haematologica 94:712-719. doi:10.3324/haematol.2008.002170
23. Sloand EM, Yong AS, Ramkissoon S, Solomou E, Bruno TC, Kim S, Fuhrer M, Kajigaya S, Barrett AJ, Young NS (2006) Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci USA 103:14483-14488. doi:10.1073/pnas.0605245103 (Pubitemid 44484776)
24. Ol'shanskaia IuV, Mikhaǐlova EA, Domracheva EV, Udovichenko AI, Davidian IuR, Vodinskaia LA, Zakharova AV, Kokhno AV, Kaplanskaia IB, Tikhonova LIu, Tsvetaeva NV, Parovichnikova EN, Savchenko VG (2006) Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation. Ter Arkh 78(31-34):36-37
25. Kearns WG, Sutton JF, Maciejewski JP, Young NS, Liu JM (2004) Genomic instability in bone marrow failure syndromes. Am J Hematol 76:220-224. doi:10.1002/ajh.20101 (Pubitemid 38828839)
26. Najean Y, Haguenauer O (1990) Long-term (5 to 20 years) evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias. Blood 76:2222-2228
27. Tiu R, Gondek L, O'Keefe C, Maciejewski JP (2007) Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes. Leukemia 21:1648-1657. doi:10.1038/sj.leu.2404757 (Pubitemid 47086755)
28. Parker CJ (2007) The pathophysiology of paroxysmal nocturnal hemoglobinuria. Exp Hematol 35:523-533. doi:10.1016/j.exphem.2007.01.046
29. Maciejewski JP, Rivera C, Kook H, Dunn D, Young NS (2001) Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones. Br J Haematol 115:1015-1022. doi:10.1046/j.1365-2141.2001.03191.x (Pubitemid 34042927)
30. Wang H, Chuhjo T, Yasue S, Omine M, Nakao S (2002) Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 100:3897-3902. doi:10.1182/blood-2002-03-0799 (Pubitemid 35396854)
31. Dunn DE, Tanawattanacharoen P, Boccuni P, Nagakura S, Green SW, Kirby MR, Kumar MS, Rosenfeld S, Young NS (1999) Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 131:401-408 (Pubitemid 29444429)
32. Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, Mizoguchi H, Omine M, Nakao S (2006) Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 107:1308-1314. doi:10.1182/blood-2005-06-2485 (Pubitemid 43242363)
33. Ishiyama K, Chuhjo T, Wang H, Yachie A, Omine M, Nakao S (2003) Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood 102:1211-1216. doi:10.1182/blood-2002-12-3706 (Pubitemid 36988024)
34. Paquette RL, Yoshimura R, Veiseh C, Kunkel L, Gajewski J, Rosen PJ (1997) Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria. Br J Haematol 96:92-97. doi:10.1046/j.1365-2141.1997.d01-1984.x
35. Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, Porwit-MacDonald A, Sjoo M, Tangen JM, Uggla B, Oberg G, Hellstrom-Lindberg E (2006) Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes. Haematologica 91:667-670 (Pubitemid 43799466)
36. Chen S, Jiang B, Da W, Gong M, Guan M (2007) Treatment of myelodysplastic syndrome with cyclosporin A. Int J Hematol 85:11-17 (Pubitemid 46193284)
37. Killick SB, Mufti G, Cavenagh JD, Mijovic A, Peacock JL, Gordon-Smith EC, Bowen DT, Marsh JC (2003) A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia. Br J Haematol 120:679-684. doi:10.1046/j.1365-2141.2003.04136.x
38. de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Socié G (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112:3099-3106. doi:10.1182/blood-2008-01-133918
39. Gupta V, Brooker C, Tooze JA, Yi QL, Sage D, Turner D, Kangasabapathy P, Marsh JC (2006) Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults. Br J Haematol 134:95-99. doi:10.1111/j.1365-2141.2006.06105.x
40. Mikhailova N, Sessarego M, Fugazza G, Caimo A, De Filippi S, van Lint MT, Bregante S, Valeriani A, Mordini N, Lamparelli T, Gualandi F, Occhini D, Bacigalupo A (1996) Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 81:418-422
41. Brodsky RA (2008) Paroxysmal nocturnal hemoglobinuria: stem cells and clonality. Hematology Am Soc Hematol Educ Program 111-115
42. Rosenfeld C, List A (2000) A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies. Leukemia 14:2-8 (Pubitemid 30068366)